Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting
Maarten van der Kroef, Monica Castellucci, Michal Mokry, Marta Cossu, Marianna Garonzi, Lara M Bossini-Castillo, Eleni Chouri, Catharina G K Wichers, Lorenzo Beretta, Elena Trombetta, Sandra Silva-Cardoso, Nadia Vazirpanah, Tiago Carvalheiro, Chiara Angiolilli, Cornelis P J Bekker, Alsya J Affandi, Kris A Reedquist, Femke Bonte-Mineur, Els J M Zirkzee, Flavia Bazzoni, Timothy R D J Radstake, Marzia Rossato
Annals of the Rheumatic Diseases Apr 2019, 78 (4) 529-538; DOI: 10.1136/annrheumdis-2018-214295
